| Victory Metals Limited (VTM) ORDINARY FULLY PAID |
Materials |
$221 |
$11.5M INSTO PLACEMENT TO TARGET ULTRA-HIGH HREO ZONES
|
26 Aug 2025 9:29AM |
$1.580 |
$1.675 |
risen by
6.01%
|
|
VTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Victory Metals Limited (VTM) announced a successful institutional placement (Insto Placement) to raise A$11.5 million.
- The placement aims to advance exploration and drilling activities, particularly focusing on ultra-high Heavy Rare Earth Oxide (HREO) zones at the North Stanmore Project.
- The funds will be used to expand the drilling campaign to better define and potentially increase resources in high-grade HREO zones.
- Institutional and sophisticated investors showed strong support for the placement, with demand exceeding the amount raised.
- The placement will be completed in two tranches, subject to shareholder approval for the second tranche.
- VTM intends to use the raised capital for further exploration, drilling, assay work, metallurgical studies, and development activities.
- The North Stanmore Project is located in Western Australia and is considered highly prospective for ionic clay-hosted rare earth elements (REEs).
- The company’s primary objective is to develop a significant REE resource with a focus on elements critical for high-tech and clean energy applications.
- The announcement highlights the strategic importance of Australian-based supply of critical minerals to global markets.
- VTM is committed to advancing the North Stanmore Project towards resource expansion and development, with the goal of establishing a globally significant critical minerals project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Calix Limited (CXL) ORDINARY FULLY PAID |
Materials |
$72 |
Calix FY25 investor presentation
|
26 Aug 2025 9:29AM |
$0.465 |
$0.335 |
fallen by
27.96%
|
|
CXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Calix Limited’s CXL technology is central to its offering, allowing industrial decarbonization through CO2 capture and utilization.
- The FY25 investor presentation covers financial performance, strategic goals, and growth outlook for the upcoming year.
- Calix is advancing commercialization with a growing project pipeline and new licensing and partnership agreements globally.
- Primary application areas for CXL include cement, lime, and lithium processing, with additional opportunities in water treatment and other sectors.
- The company targets substantial revenue growth, improved operating margins, and increased technology adoption in FY25.
- Calix’s strategy includes global expansion, scaling commercial projects, and leveraging intellectual property.
- Environmental, social, and governance (ESG) considerations are integral to Calix’s operations and growth plans.
- The presentation highlights Calix’s role in supporting the global transition to a net zero emissions economy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$813 |
FY25 Investor Presentation
|
26 Aug 2025 9:29AM |
$2.720 |
$2.180 |
fallen by
19.85%
|
|
IDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Integral Diagnostics Limited is a leading provider of diagnostic imaging services in Australia and New Zealand.
- The FY25 Investor Presentation reviews the company's FY24 financial results, including revenue growth and EBITDA performance.
- IDX highlights operational improvements and ongoing efficiency initiatives to drive profitability.
- The company outlines its technology and digital transformation efforts to enhance service delivery and clinical outcomes.
- Expansion strategies include targeted investments, network growth, and potential acquisitions.
- IDX discusses its response to healthcare policy changes and market dynamics impacting the diagnostic imaging sector.
- The presentation emphasizes a focus on quality, patient care, and clinical leadership.
- Future priorities involve operational excellence, innovation, and disciplined capital management.
- IDX provides financial guidance for FY25 and reiterates its commitment to delivering shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ingenia Communities Group (INA) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,826 |
Strategy Delivering - Underlying EPS Guidance Exceeded
|
26 Aug 2025 9:29AM |
$5.960 |
$4.480 |
fallen by
24.83%
|
|
| Calix Limited (CXL) ORDINARY FULLY PAID |
Materials |
$72 |
FY25 Results - Calix delivers revenue growth & milestones
|
26 Aug 2025 9:28AM |
$0.465 |
$0.335 |
fallen by
27.96%
|
|
CXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Calix delivered significant revenue growth for FY25.
- Milestones achieved in commercialization of LEILAC technology for carbon reduction.
- Key advancements in CXL process and global partnerships with major cement companies.
- Expansion of LEILAC project footprint in Europe and other regions.
- Growth in water and wastewater treatment business segments.
- Ongoing development of new product lines and strengthening of R&D pipeline.
- Increased investor interest and substantial government grant support.
- Solid financial position prepared for further innovation and commercial scale-up in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Argo Global Listed Infrastructure Limited (ALI) ORDINARY FULLY PAID |
Financials |
$490 |
Weekly NTA estimate - Fri 22.8.25
|
26 Aug 2025 9:28AM |
$2.430 |
$2.600 |
risen by
7%
|
|
| Terra Metals Limited (TM1) ORDINARY FULLY PAID |
Materials |
$237 |
Trading Halt
|
26 Aug 2025 9:28AM |
$0.084 |
$0.230 |
risen by
173.81%
|
|
TM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Terra Metals Limited (ASX: TM1) has requested a trading halt.
- The trading halt is due to a pending announcement regarding a material acquisition.
- The halt will remain in place until the earlier of normal trading on 13 June 2024 or the announcement release.
- The trading halt was requested under ASX Listing Rule 17.1.
- The purpose of the halt is to ensure the market is fully informed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Calix Limited (CXL) ORDINARY FULLY PAID |
Materials |
$72 |
Calix FY25 Appendix 4G
|
26 Aug 2025 9:27AM |
$0.465 |
$0.335 |
fallen by
27.96%
|
|
| Nutritional Growth Solutions Ltd (NGS) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Change in substantial holding
|
26 Aug 2025 9:27AM |
$0.022 |
$0.022 |
fallen by
0%
|
|
| Polynovo Limited (PNV) ORDINARY FULLY PAID |
Health Care |
$604 |
Webcast Recording - FY25 Results Presentation
|
26 Aug 2025 9:27AM |
$1.200 |
$0.875 |
fallen by
27.08%
|
|
| Calix Limited (CXL) ORDINARY FULLY PAID |
Materials |
$72 |
Calix Sustainability Report 2025
|
26 Aug 2025 9:27AM |
$0.465 |
$0.335 |
fallen by
27.96%
|
|
| Ingenia Communities Group (INA) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,826 |
Dividend/Distribution - INA
|
26 Aug 2025 9:27AM |
$5.960 |
$4.480 |
fallen by
24.83%
|
|
| Ingenia Communities Group (INA) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,826 |
Appendix 4E and Financial Reports
|
26 Aug 2025 9:27AM |
$5.960 |
$4.480 |
fallen by
24.83%
|
|
| Calix Limited (CXL) ORDINARY FULLY PAID |
Materials |
$72 |
Calix Corporate Governance Statement 2025
|
26 Aug 2025 9:26AM |
$0.465 |
$0.335 |
fallen by
27.96%
|
|
| Calix Limited (CXL) ORDINARY FULLY PAID |
Materials |
$72 |
Calix Annual Report 2025
|
26 Aug 2025 9:26AM |
$0.465 |
$0.335 |
fallen by
27.96%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$286 |
Update - Notification of buy-back - AMH
|
26 Aug 2025 9:26AM |
$1.065 |
$0.910 |
fallen by
14.55%
|
|
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$106 |
Two Additional Strategic Partnerships Advance FDA Submission
|
26 Aug 2025 9:25AM |
$0.500 |
$0.690 |
risen by
38%
|
|
| Locksley Resources Limited (LKY) ORDINARY FULLY PAID |
Materials |
$25 |
Agreement with GreenMet to Advance US Government Engagement
|
26 Aug 2025 9:25AM |
$0.320 |
$0.066 |
fallen by
79.38%
|
|
| Syrah Resources Limited (SYR) ORDINARY FULLY PAID |
Materials |
$244 |
Application for quotation of securities - SYR
|
26 Aug 2025 9:25AM |
$0.295 |
$0.105 |
fallen by
64.41%
|
|
| Melbana Energy Limited (MAY) ORDINARY FULLY PAID |
Energy |
$17 |
Variation of Permits Hudson Prospect
|
26 Aug 2025 9:25AM |
$0.018 |
$0.005 |
fallen by
75%
|
|
| Godolphin Resources Limited (GRL) ORDINARY FULLY PAID |
Materials |
$18 |
Trading Halt
|
26 Aug 2025 9:25AM |
$0.016 |
$0.021 |
risen by
31.25%
|
|
GRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Godolphin Resources Limited (GRL) has requested a trading halt on its securities.
- The trading halt is effective from 21 June 2024.
- The reason for the trading halt is to allow for an announcement about a proposed capital raising.
- The trading halt will last until the earlier of the announcement’s release or the commencement of trading on 25 June 2024.
- The halt is requested to ensure an orderly market while the announcement is being prepared.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mader Group Limited (MAD) ORDINARY FULLY PAID |
Industrials |
$1,512 |
FY25 Results Presentation
|
26 Aug 2025 9:25AM |
$8.350 |
$7.430 |
fallen by
11.02%
|
|
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$813 |
FY25 Results Announcement
|
26 Aug 2025 9:25AM |
$2.720 |
$2.180 |
fallen by
19.85%
|
|
IDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Integral Diagnostics Limited (IDX) released its FY25 Results Announcement.
- The company reported revenue growth and improved profitability for the fiscal year.
- Operational highlights include investments in technology and infrastructure to enhance service delivery.
- IDX addressed challenges such as regulatory changes and increasing market competition.
- Cost management and efficiency improvements were implemented to support sustainable growth.
- The company emphasized its commitment to high-quality diagnostic services.
- Strategic initiatives focus on expanding service offerings and geographic footprint.
- IDX provided guidance for the upcoming fiscal year, outlining financial and operational priorities.
- The announcement reinforces IDX’s long-term strategic goals and value creation for stakeholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Calix Limited (CXL) ORDINARY FULLY PAID |
Materials |
$72 |
Calix FY25 Appendix 4E
|
26 Aug 2025 9:25AM |
$0.465 |
$0.335 |
fallen by
27.96%
|
|
CXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Calix Limited released its FY25 Appendix 4E on 23 August 2023.
- The company achieved notable revenue growth and positive operating results for the fiscal year.
- Calix advanced its CXL technology platform, contributing to global CO2 emissions reduction.
- Strategic partnerships and international expansion were significant themes during the year.
- The company made substantial investments in R&D and intellectual property.
- Sustainability and innovation were central to Calix’s operations and strategy.
- The Appendix 4E includes detailed financial statements and disclosures.
- Calix’s core business operations continued to strengthen and diversify.
- Shareholders are informed of key risks, future outlook, and ongoing initiatives.
- The document reflects Calix’s focus on creating long-term value through technology and sustainability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MyState Limited (MYS) ORDINARY FULLY PAID |
Financials |
$838 |
Key 2025-2026 Financial Calendar Dates
|
26 Aug 2025 9:24AM |
$4.320 |
$4.920 |
risen by
13.89%
|
|